OTC Healthcare in the Philippines
Euromonitor International's OTC Healthcare in the Philippines market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 99 | Publication date: Apr 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouth care; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
OTC Healthcare Remains Vibrant in 2008
OTC healthcare posted a fairly good performance in 2008, despite the challenges posed by the limited disposable incomes of Filipinos, which tended to limit purchases due to the rising cost of living. The overall performance was boosted by active marketing campaigns, which mostly focused on television advertisements and greater visibility in retail channels through more exciting packaging, and pricing strategies which offered better value for money for consumers.
RA 9502 Finally Passes Into Law
The enactment into law of RA 9502 (Universally Accessible Cheaper and Quality Medicines Act of 2008) showed conflicting positive and negative impacts on OTC healthcare during 2008. Industry sources claim that the new law will force drug manufacturers to reduce their costs in order to meet the requirement of providing lower retail prices for consumers. However, there are those who remain optimistic, due to the fact that the law invites more companies to engage in more OTC medicines, as use of generics will become more pronounced, allowing consumers to have more choice. Whatever the effects, RA 9502 is expected to significantly influence the dynamics of the OTC healthcare market in the future.
United Laboratories Inc Remains the Market Leader
United Laboratories Inc (Unilab) continued to dominate the OTC healthcare market in 2008. A domestic player with great experience of and familiarity with Filipino consumers, and many years of providing quality healthcare products, Unilab continued to earn revenue from a wide range of products, thanks to formidable advertising campaigns which appealed to consumers. Unilab's well-established distribution system also helped it to maintain its market leadership.
Chemists/Pharmacies and Parapharmacies/Drugstores Aid the Growth of OTC Healthcare
Chemists/pharmacies and parapharmacies/drugstores continued to boost the performance of OTC healthcare by providing avenues for growth. Having counters where consumers can easily look at products and compare product information, pricing and promotions gives people more choice. With more and more of these pharmacies advocating generics, chemists/pharmacies is expected to remain the main channel for growth for OTC healthcare products. Over time, players in the market should develop strategies to further enhance their performance in this popular distribution channel.
Higher and Faster Growth Over the Forecast Period
The forecast period may see the challenge of limited disposable incomes amongst consumers, but the prospects for the OTC healthcare market are expected to be more positive, and growth faster compared with the review period. Due to the slowdown, consumers are expected to prefer self-medication over the forecast period. They will use preventative measures through the use of OTC medicines which enhance natural resistance and facilitate faster healing and wellbeing, since self-medication is relatively cheaper than going to a doctor. Thus, more consumers are expected to purchase OTC healthcare products. Manufacturers should be vigilant in maintaining their visibility amongst consumers, and ensure that they are price-sensitive or provide better value for money to ensure continued patronage of their products and the needed growth for the market.
Table of contents
OTC HEALTHCARE IN THE PHILIPPINES : MARKET INSIGHT
EXECUTIVE SUMMARY
OTC Healthcare Remains Vibrant in 2008
RA 9502 Finally Passes Into Law
United Laboratories Inc Remains the Market Leader
Chemists/Pharmacies and Parapharmacies/Drugstores Aid the Growth of OTC Healthcare
Higher and Faster Growth Over the Forecast Period
KEY TRENDS AND DEVELOPMENTS
Republic Act 9502 Influences the Dynamics of Pharmaceuticals in 2008
Limited Disposable Incomes Pushes Demand for Cheaper, Affordable Drugs
Filipinos' Fondness for Self-medication Brings Hope to OTC Healthcare
Saving Grace in Privilege/Value Cards and Discount Coupons
Multinationals Have a Strong Presence in OTC Healthcare
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
De-listing or De-reimbursement
Advertising
Packaging and Labelling
Distribution
Vitamins & Dietary Supplements Registration and Classification
Self-medication and Preventative Medicine
Generics
Switches
DEFINITIONS
Summary 1 Research Sources
LOCAL COMPANY PROFILES - PHILIPPINES
INTERNATIONAL PHARMACEUTICALS INC - OTC HEALTHCARE - PHILIPPINES
STRATEGIC DIRECTION
KEY FACTS
Summary 2 International Pharmaceuticals Inc: Key Facts
COMPANY BACKGROUND
COMPETITIVE POSITIONING
Summary 3 International Pharmaceuticals Inc: Competitive Position 2008
PASCUAL LABORATORIES INC - OTC HEALTHCARE - PHILIPPINES
STRATEGIC DIRECTION
KEY FACTS
Summary 4 Pascual Laboratories Inc: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 5 Pascual Laboratories Inc: Competitive Position 2008
PHILUSA CORP - OTC HEALTHCARE - PHILIPPINES
STRATEGIC DIRECTION
KEY FACTS
Summary 6 Philusa Corp: Key Facts
COMPANY BACKGROUND
COMPETITIVE POSITIONING
Summary 7 Philusa Corp: Competitive Position 2008
UNITED LABORATORIES INC - OTC HEALTHCARE - PHILIPPINES
STRATEGIC DIRECTION
KEY FACTS
Summary 8 United Laboratories Inc: Key Facts
COMPANY BACKGROUND
COMPETITIVE POSITIONING
Summary 9 United Laboratories Inc: Competitive Position 2008
UNIVERSAL ROBINA CORP - OTC HEALTHCARE - PHILIPPINES
STRATEGIC DIRECTION
KEY FACTS
Summary 10 Universal Robina Corp: Key Facts
Summary 11 Universal Robina Corp: Operational Indicators 2006-2007
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 12 Universal Robina Corp: Competitive Position 2008
ANALGESICS IN THE PHILIPPINES
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 11 Sales of Analgesics by Subsector: Value 2003-2008
Table 12 Sales of Analgesics by Subsector: % Value Growth 2003-2008
Table 13 Herbal vs Standard Topical Analgesics 2003-2008
Table 14 Topical Analgesics by Format: % Value Breakdown 2004-2008
Table 15 Analgesics Company Shares by Value 2004-2008
Table 16 Analgesics Brand Shares by Value 2005-2008
Table 17 Forecast Sales of Analgesics by Subsector: Value 2008-2013
Table 18 Forecast Sales of Analgesics by Subsector: % Value Growth 2008-2013
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN THE PHILIPPINES
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2003-2008
Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2003-2008
Table 21 Sales of Decongestants by Type: Value 2003-2008
Table 22 Sales of Decongestants by Type: % Value Growth 2003-2008
Table 23 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2003-2008
Table 24 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2003-2008
Table 25 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2003-2008
Table 26 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2004-2008
Table 27 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2005-2008
Table 28 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2008-2013
Table 29 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2008-2013
DIGESTIVE REMEDIES IN THE PHILIPPINES
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 30 Sales of Digestive Remedies by Subsector: Value 2003-2008
Table 31 Sales of Digestive Remedies by Subsector: % Value Growth 2003-2008
Table 32 Herbal vs Standard Digestive Remedies 2003-2008
Table 33 Digestive Remedies Company Shares by Value 2004-2008
Table 34 Digestive Remedies Brand Shares by Value 2005-2008
Table 35 Forecast Sales of Digestive Remedies by Subsector: Value 2008-2013
Table 36 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2008-2013
MEDICATED SKIN CARE IN THE PHILIPPINES
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 37 Sales of Medicated Skin Care by Subsector: Value 2003-2008
Table 38 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
Table 39 Acne Treatments by Format: % Value Breakdown 2004-2008
Table 40 Medicated Skin Care Company Shares by Value 2004-2008
Table 41 Medicated Skin Care Brand Shares by Value 2005-2008
Table 42 Acne Treatments Brand Shares by Value 2005-2008
Table 43 Hair Loss Treatments Brand Shares by Value 2005-2008
Table 44 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
Table 45 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013
VITAMINS AND DIETARY SUPPLEMENTS IN THE PHILIPPINES
HEADLINES
TRENDS
Vitamins
Dietary Supplements
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Summary 13 Dietary Supplements: Brand Ranking by Positioning 2008
Table 46 Sales of Vitamins and Dietary Supplements by Subsector: Value 2003-2008
Table 47 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2003-2008
Table 48 Folic Acid v Other B Vitamins 2004-2008
Table 49 Dietary Supplements by Positioning 2006-2008
Table 50 Vitamins and Dietary Supplements Company Shares by Value 2004-2008
Table 51 Vitamins and Dietary Supplements Brand Shares by Value 2005-2008
Table 52 Vitamins Brand Shares by Value 2005-2008
Table 53 Dietary Supplements Brand Shares by Value 2005-2008
Table 54 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2008-2013
Table 55 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2008-2013
NRT SMOKING CESSATION AIDS IN THE PHILIPPINES
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
EYE CARE IN THE PHILIPPINES
TRENDS
SECTOR DATA
Table 56 Sales of Eye Care by Subsector: Value 2003-2008
Table 57 Sales of Eye Care by Subsector: % Value Growth 2003-2008
Table 58 Standard Eye Care by Type: % Value Breakdown 2007-2008
Table 59 Eye Care Company Shares by Value 2004-2008
Table 60 Eye Care Brand Shares by Value 2005-2008
Table 61 Forecast Sales of Eye Care by Subsector: Value 2008-2013
Table 62 Forecast Sales of Eye Care by Subsector: % Value Growth 2008-2013
EAR CARE IN THE PHILIPPINES
TRENDS
SECTOR DATA
Table 63 Sales of Ear Care: Value 2003-2008
Table 64 Sales of Ear Care: % Value Growth 2003-2008
Table 65 Ear Care Company Shares by Value 2004-2008
Table 66 Ear Care Brand Shares by Value 2005-2008
Table 67 Forecast Sales of Ear Care: Value 2008-2013
Table 68 Forecast Sales of Ear Care: % Value Growth 2008-2013
ADULT MOUTH CARE IN THE PHILIPPINES
TRENDS
SECTOR DATA
Table 69 Sales of Adult Mouth Care: Value 2003-2008
Table 70 Sales of Adult Mouth Care: % Value Growth 2003-2008
Table 71 Adult Mouth Care Company Shares by Value 2004-2008
Table 72 Adult Mouth Care Brand Shares by Value 2005-2008
Table 73 Forecast Sales of Adult Mouth Care: Value 2008-2013
Table 74 Forecast Sales of Adult Mouth Care: % Value Growth 2008-2013
WOUND TREATMENTS IN THE PHILIPPINES
TRENDS
SECTOR DATA
Table 75 Sales of Wound Treatments by Subsector: Value 2003-2008
Table 76 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008
Table 77 Wound Treatments Company Shares by Value 2004-2008
Table 78 Wound Treatments Brand Shares by Value 2005-2008
Table 79 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
Table 80 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013
OTC OBESITY IN THE PHILIPPINES
TRENDS
SECTOR DATA
Table 81 Sales of OTC Obesity: Value 2005-2008
Table 82 Sales of OTC Obesity: % Value Growth 2005-2008
Table 83 OTC Obesity Company Shares by Value 2005-2008
Table 84 OTC Obesity Brand Shares by Value 2005-2008
Table 85 Forecast Sales of OTC Obesity: Value 2008-2013
Table 86 Forecast Sales of OTC Obesity: % Value Growth 2008-2013